Real-World Adherence and Safety of Glucagon Like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity or Type 2 Diabetes

Associate Professor & Fellowship Director

Md-Peds-Endocrinology, College-Medicine

angelina@mail.ufl.edu

Associate Professor & Chair, Pharmaceutical Outcomes & Policy; Co-Director, Center For Integrative Cardiovascular and Metabolic Disease

Ph-Pharm Outcomes & Policy, College-Pharmacy

ssmith@cop.ufl.edu

Sarah Westen

Director, Diabetes Behavioral Medicine and Psychology; Assistant Director, Behavioral Research, Uf Diabetes Institute; Assistant Director, Internship Program in Clinical Psychology; Clinical Associate Professor

Hp-Clinical - Hlth Psychology, College-Publ Hlth - Hlth Profs

westens@phhp.ufl.edu

Jingchuan Guo

Courtesy Faculty

Ph-Pharm Outcomes & Policy, College-Pharmacy

guoj1@ufl.edu

Pareeta Kotecha

Predoc Fellowship

Ph-Pharm Outcomes & Policy-Gen, College-Pharmacy

pkotecha@ufl.edu

Award	$60,000.00
Begin Date	May 1, 2026
End Date	April 30, 2028

Real-World Adherence and Safety of Glucagon Like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity or Type 2 Diabetes

Investigators

Funding

Research Terms

About

Discover

Connect

Keyword Search

Browse by STEM